Patent · US Active

Method of eliciting an immune response against pandemic influenza virus

US8999353B2 · kind B2 · utility

0Cited by
2References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2008
Grant dateApr 7, 2015
Priority date
Expiry dateJan 11, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16234
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for eliciting or inducing a protective immune response in a subject against a pandemic subtype of influenza virus comprises administering to the subject a composition comprising (i) at least one immunogen of an endemic influenza subtype, and (ii) an immunogen-free immunostimulating complex as adjuvant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.